VXLLDVaxil Bio Ltd.

About Vaxil Bio Ltd. (VXLLD)

Vaxil Bio Ltd. (VXLLD) is a Biotechnology company headquartered in Toronto, ON, Canada whose shares trade over-the-counter on the Pink tier.

Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company develops ImMucin, a MUC1 SP-derived vaccine that has completed a Phase 1/2 clinical trial for the treatment of multiple myeloma. It is also developing SP-based COVID-19 and tuberculosis vaccine/treatment candidate.

VXLLD key facts

Ticker symbol

VXLLD

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Toronto, ON, Canada

Country of incorporation

CA

Estimated market cap

$38.1K (as of Aug 1, 2025)

Shares outstanding

2,739,580

Reporting standard

International Reporting: TSX Venture Exchange

Audit status

Audited

Fiscal year end

12/31

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with V